Biohacker hoping to live to 160 reveals alarming diagnosis: My stomach is eating itself – Fox News

Fox News

Image Credit: Fox News

Please find more details at Fox News

Summary

NEW You can now listen to Fox News articles!

Bryan Johnson, a biohacker and longevity guru who has claimed we may be the first generation who wont die, revealed he has an autoimmune condition causing his stomach to eat itself.

The Los Angeles-based tech entrepreneur, 48, has previously shared…

Source: Fox News

Read More

(0)

AI News Q&A (Free Content)

This content is freely available. No login required. Disclaimer: Following content is AI generated from various sources including those identified below. Always check for accuracy. No content here is an advice. Please use the contact button to share feedback about any inaccurate content generated by AI. We sincerely appreciate your help in this regard.

Q1: What is Bryan Johnson's background, and what is his connection to anti-aging and longevity?

A1: Bryan Johnson is an American entrepreneur and venture capitalist known for his anti-aging efforts. He founded Kernel, a company focused on brain activity monitoring, and OS Fund, a venture capital firm investing in science and technology. He gained attention for his 'Project Blueprint,' aimed at extending human lifespan with a philosophy of 'don't die' and was featured in the documentary 'Don't Die: The Man Who Wants to Live Forever.'

Q2: What is autoimmune gastritis, and how does it affect the body?

A2: Autoimmune gastritis (AIG) is a chronic condition where the immune system attacks the stomach lining, affecting acid-producing cells. This can lead to nutritional deficiencies, anemia, and increased cancer risk over time. AIG is often undetected and may affect 2–5% of people, manifesting as iron deficiency and related symptoms.

Q3: How has Bryan Johnson's health journey evolved over time?

A3: Bryan Johnson's health issues began with hypothyroidism diagnosed at age 21, managed with hormone replacement therapy. Over the years, he experienced low ferritin levels, an early sign of iron deficiency linked to AIG. His diagnosis of autoimmune gastritis followed a decade-long diagnostic process involving endoscopies and anti-parietal cell antibody tests.

Q4: What are some potential causes of autoimmune gastritis, based on recent reports?

A4: Recent reports suggest that autoimmune gastritis may be linked to chronic stress and an unhealthy lifestyle. Bryan Johnson believes his own health issues may have stemmed from such factors earlier in life, contributing to the development of an autoimmune process affecting both his thyroid and stomach lining.

Q5: What treatments is Bryan Johnson pursuing for his autoimmune condition?

A5: Bryan Johnson is undergoing iron infusions to address iron deficiency caused by autoimmune gastritis. He is also engaged in routine monitoring of ferritin and iron levels and is exploring additional experimental treatments as part of his broader longevity and health optimization strategy.

Q6: What role does the interplay between iron deficiency and thyroid function play in autoimmune gastritis?

A6: There is a bi-directional relationship where low iron levels impair the conversion of thyroid hormone into its active form, and an underactive thyroid can affect how the body utilizes iron. This interplay complicates conditions like autoimmune thyroid disease and autoimmune gastritis, reinforcing symptoms and deficiencies.

Q7: How does Bryan Johnson's approach to longevity reflect current trends in health and wellness?

A7: Bryan Johnson's approach, involving significant investment in anti-aging therapies and health optimization, reflects a growing trend in health and wellness focused on extending lifespan and improving quality of life. His use of advanced medical interventions and public sharing of his health journey exemplifies the modern biohacking movement.

References:

  • Bryan Johnson
  • This longevity guru is trying to live forever. It may have made him sick
  • Bryan Johnson diagnosed with autoimmune gastritis, plans experimental treatment approach
  • Bryan Johnson's autoimmune disease raises alarm on common deficiency